Digestive Enzymes and Wegovy: Separating Fact from a Persistent Myth

The myth that needs correcting: Wegovy does not deplete your digestive enzymes

Search for Wegovy and digestion and you will find supplement sellers framing enzyme tablets as a necessary companion to GLP-1 treatment. The claim, broadly, is that semaglutide interferes with the enzymes your pancreas and small intestine release to digest fats, proteins and carbohydrates. It does not. Semaglutide binds to GLP-1 receptors on cells involved in appetite and insulin signalling, those receptors are not the same machinery as the secretory cells that produce lipase, amylase or protease. There is no established pharmacological pathway through which Wegovy reduces enzyme output.

The separate question of how semaglutide interacts with metabolic enzyme pathways is worth understanding, but it is a different topic entirely from digestive enzyme secretion. Conflating the two is how the supplement myth gains traction.

The NHS patient guidance on semaglutide does not list enzyme supplementation among the things patients should take alongside treatment, and the Mounjaro SmPC and the Wegovy SmPC on the Electronic Medicines Compendium contain no such recommendation. That absence is meaningful.

What is actually slowing things down: gastric emptying, not enzyme activity

The digestive discomfort that leads people to wonder about enzymes almost always traces back to one real and well-evidenced mechanism: GLP-1 receptor activation slows the rate at which the stomach releases its contents into the small intestine. Food sits in the stomach longer. That creates a feeling of fullness, which is partly why Wegovy reduces appetite, but it can also produce bloating, belching, nausea and a heavy sensation after eating that some people interpret as poor digestion.

That experience is real. The explanation for it is not enzyme deficiency. You can read more about how Wegovy affects digestion in detail, including what the clinical evidence shows about how long these effects typically last after dose changes. The key practical point is this: if meals feel uncomfortable, the cause is almost certainly slower transit, not a missing enzyme. Adjusting what and when you eat (smaller portions, less fat per sitting, more time between bites) tends to help more than a supplement.

Persistent indigestion on Wegovy is a recognised side effect pattern worth discussing with whoever is managing your treatment, particularly around dose increases.

Should you take digestive enzyme supplements with Wegovy?

There is no clinical trial evidence supporting enzyme supplementation as a co-therapy with semaglutide. The NHS England guidance on weight-management injections does not endorse it. Supplement sellers are not regulated in the same way pharmacies are, and the quality and dosage of over-the-counter enzyme products varies considerably.

More practically: taking an enzyme supplement does not address the actual cause of most GI symptoms on Wegovy, which is gastric emptying rate. If anything, adding unreviewed supplements to a regimen managed by a prescriber introduces unnecessary variables. A question our prescribers hear fairly often is whether patients should adjust their supplement or vitamin intake when starting treatment, the short answer is always to check first, because staying active and nourishing well on Wegovy does matter, but the specifics belong in a clinical conversation, not a supplement aisle.

If you are thinking about the cost of private Wegovy treatment and wondering whether stacking supplements on top adds up financially, it is worth knowing that legitimate treatment through a regulated pharmacy already includes clinical oversight, the kind that means you have someone to call when side effects appear, rather than reaching for the nearest supplement as a guess.

The NHS page on semaglutide (NHS.UK) covers common side effects and how to manage them; it is a reliable starting point before drawing any conclusions about what to add to your routine.

When digestive symptoms during treatment do need proper attention

Most GI side effects on Wegovy are mild to moderate and settle within a few weeks, particularly after the body adjusts to a new dose. Nausea, loose stools, and that uncomfortable fullness are common, especially in the weeks after an increase. Serious symptoms are rarer but real: severe, persistent abdominal pain that radiates to the back should prompt urgent medical attention, the MHRA highlighted acute pancreatitis as an infrequent but recognised risk with GLP-1 medicines in a January 2026 Drug Safety Update.

You can report unexpected or concerning side effects through the MHRA Yellow Card scheme, and you should always let your prescriber know if digestive symptoms are affecting your ability to eat properly or are not settling between doses. That is especially true if you order treatment on the sort of irregular schedule life creates (a bank holiday delay, a fortnight away in August) because gaps and restarts can temporarily intensify side effects.

For a fuller picture of what Wegovy is and how it works before any of this, the Wegovy overview on this site covers the mechanism, the evidence and what a clinical assessment involves. If you have questions that belong in front of a prescriber rather than a search engine, speak to our prescribers through a free consultation and get an answer that accounts for your own picture.